1. Henry Masur. Management of Opportunistic Infections Associated with Human Immunodeficiency Virus Infection. In: Bennett JE, Dolin R, Blaser MJ eds. Mandell, Douglas, and Bennett’s
Principles and Practice of Infectious Diseases, Ninth Edition. Philadelphia:Elsevier, 2020: 1761-1786.e6.
2. Guidelines for Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. December 16, 2024. https://clinicalinfo.hiv.gov/en/guidelines/hiv-clinical-guideli-
nes-adult-and-adolescent-opportunistic-infections/introduction?view=full (Erişim 03.03.2025).
3. Buchacz K, Lau B, Jing Y, et al. Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000-2010. J Infect
Dis. 2016;214(6):862-872.
4. Kelly C, Gaskell KM, Richardson M, Klein N, Garner P, MacPherson P. Discordant immune response with antiretroviral therapy in HIV-1: a systematic review of clinical outcomes. PLoS One.
2016;11(6):e0156099.
5. EACS Guidelines, Version 12.1 November, 2024. https://eacs.sanfordguide.com/ (Erişim 03.03.2025)
6. British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of pulmonary opportunistic infections 2024.
7. HIV/AIDS Tanı Tedavi ve İzlem El Kitabı https://www.klimik.org.tr/wp-content/uploads/2024/02/HIV-AIDS.El_.Kitabi_Surum.3.pdf
8. Gandhi RT, Landovitz RJ, Sax PE, et al. Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel. JAMA.
2025; 18;333(7):609-628.
9. McDonald EG, Afshar A, Assiri B, et al. Pneumocystis jirovecii pneumonia in people living with HIV: a review. Clin Microbiol Rev ;2024 ; 37:e00101-22.
10. Wesołowski R, Pawłowska M, Smoguła M, Szewczyk-Golec K. Advances and Challenges in Diagnostics of Toxoplasmosis in HIV-Infected Patients. Pathogens. 2023; 12(1):110.
11. Munawwar A, Singh S. Human Herpesviruses as Copathogens of HIV Infection, Their Role in HIV Transmission, and Disease Progression. J Lab Physicians. 2016;8(1):5-18.
12. Stinn T, Kuntz S, Varon D, et al. Subclinical Genital Herpes Shedding in HIV/Herpes Simplex Virus 2-Coinfected Women during Antiretroviral Therapy Is Associated with an Increase in HIV
Tissue Reservoirs and Potentially Promotes HIV Evolution. J Virol 2020; 95:10.1128/jvi.01606-20.
13. Adland E, Klenerman P, Goulder P, Matthews PC. Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era. Front Microbiol. 2015;
24;6:1016.
14. Lalonde RG, Boivin G, Deschênes J, et al. Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS. Can J Infect Dis Med Microbiol. 2004 ;15(6):327-35.
15. Dunham SR, Schmidt R, Clifford DB. Treatment of Progressive Multifocal Leukoencephalopathy Using Immune Restoration. Neurotherapeutics. 2020;17(3):955-965.
16. Keyvanfar A, Najafiarab H, Talebian N, Tafti MF, Adeli G, Ghasemi Z, Tehrani S. Drug-resistant oral candidiasis in patients with HIV infection: a systematic review and meta-analysis. BMC
Infect Dis. 2024; 31;24(1):546.
17. McHale TC, Boulware DR, Kasibante J, Ssebambulidde K, Skipper CP, Abassi M. Diagnosis and management of cryptococcal meningitis in HIV-infected adults. Clin Microbiol Rev. 2023;
20;36(4):e0015622.
18. Perez F, Caceres DH, Ford N, et al. For The Guideline Development Group For Diagnosing And Managing Disseminated Histoplasmosis Among People Living With HIV. Summary of Gui-
delines for Managing Histoplasmosis among People Living with HIV. J Fungi (Basel). 2021; 12;7(2):134.
19. Galgiani JN, Ampel NM, Blair JE, et al. 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis. Clin Infect Dis.
2016;15;63(6):e112-46.
20. British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of nontuberculous mycobacteria 2024.
21. Chadwick DR, Sutherland RK, Raffe S, Pool E, Beadsworth M. British HIV Association guidelines on the management of opportunistic infection in people living with HIV: the clinical ma-
nagement of gastrointestinal opportunistic infections 2020. HIV Med. 2020 ;21 Suppl 5:1-19.
22. Ren M, Dashwood T, Walmsley S. The Intersection of HIV and Syphilis: Update on the Key Considerations in Testing and Management. Curr HIV/AIDS Rep. 2021;18(4):280-288.
23. Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA. Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms. Clin Infect Dis 2009;
48:816.
24. Libois A, De Wit S, Poll B, Garcia F, Florence E, Del Rio A, et al. HIV and syphilis: when to perform a lumbar puncture. Sex Transm Dis 2007; 34:141.
25. Alter MJ. Epidemiology of viral hepatitis and HIV co-infection.Journal of Hepatology, 2006; 44, S6 – S9.
26. PAHO: Preventıon, Care And Treatmentof Vıral Hepatıtıs B and C Coınfectıon In People Lıvıng Wıth HIV. https://www.paho.org/sites/default/files/2019-12/2019-cde-recomm-prev-care-tx-
hep-hiv-en.pdf